David Munday1, Jane Leaman2, Éamonn O'Moore2, Emma Plugge3. 1. Nuffield Department of Population Health, Oxford School of Public Health, University of Oxford, Oxford, UK. 2. National Health and Justice Team, Public Health England and UK Collaborating Centre, WHO Health in Prisons Programme, Premier House, Reading, UK. 3. Nuffield Department of Clinical Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, UK.
Abstract
BACKGROUND: people in prison often experience poor health. Those aged 50 and over are the fastest growing age-group in prison and present particular challenges to criminal justice systems around the world. Non-communicable diseases (NCDs) account for two-thirds of deaths globally and no estimate of the prevalence of NCDs in this vulnerable population exists. METHODS: we searched PubMed, Medline, CINAHL, EMBASE and Global Health databases to identify original research papers that met our pre-defined inclusion criteria. No date or language restrictions were applied. Two authors undertook full-text screening as well as quality assessment and data extraction for all included studies. A random effects model was used to calculate pooled prevalence of any disease that was reported in two or more articles. RESULTS: the initial search identified 2,712 articles. 119 underwent full-text screening with 26 meeting the inclusion criteria. This provided prevalence data on 28 NCDs in 93,862 individuals from prisons in 11 countries. Pooled prevalence for the most significant NCDs was a follows; cancer 8% (95% CI 6-10%), cardiovascular disease 38% (95% CI 33-42%), hypertension 39% (95% CI 32-47%), diabetes 14% (95% CI 12-16%), COPD prevalence estimates ranged from 4% to 18%. Heterogeneity across studies was high. CONCLUSIONS: those in prison over 50 years of age experience a high burden of NCDs which is often higher than younger prison and age-matched community peers. This health inequality is influenced by lifestyle, environmental and societal factors. Prison services should be adapted to serve the needs of this growing population.
BACKGROUND:people in prison often experience poor health. Those aged 50 and over are the fastest growing age-group in prison and present particular challenges to criminal justice systems around the world. Non-communicable diseases (NCDs) account for two-thirds of deaths globally and no estimate of the prevalence of NCDs in this vulnerable population exists. METHODS: we searched PubMed, Medline, CINAHL, EMBASE and Global Health databases to identify original research papers that met our pre-defined inclusion criteria. No date or language restrictions were applied. Two authors undertook full-text screening as well as quality assessment and data extraction for all included studies. A random effects model was used to calculate pooled prevalence of any disease that was reported in two or more articles. RESULTS: the initial search identified 2,712 articles. 119 underwent full-text screening with 26 meeting the inclusion criteria. This provided prevalence data on 28 NCDs in 93,862 individuals from prisons in 11 countries. Pooled prevalence for the most significant NCDs was a follows; cancer 8% (95% CI 6-10%), cardiovascular disease 38% (95% CI 33-42%), hypertension 39% (95% CI 32-47%), diabetes 14% (95% CI 12-16%), COPD prevalence estimates ranged from 4% to 18%. Heterogeneity across studies was high. CONCLUSIONS: those in prison over 50 years of age experience a high burden of NCDs which is often higher than younger prison and age-matched community peers. This health inequality is influenced by lifestyle, environmental and societal factors. Prison services should be adapted to serve the needs of this growing population.
Authors: Mohsen Shati; Ali Alami; Seyede Salehe Mortazavi; Sana Eybpoosh; Mohammad Hassan Emamian; Manije Moghadam Journal: Med J Islam Repub Iran Date: 2020-11-10
Authors: Wendy M Rice; Dimple Y Chudasama; James Lewis; Francis Senyah; Isaac Florence; Simon Thelwall; Lisa Glaser; Maciej Czachorowski; Emma Plugge; Hilary Kirkbride; Gavin Dabrera; Theresa Lamagni Journal: Emerg Infect Dis Date: 2021-08 Impact factor: 6.883